Thrombotic risk assessment in APS: the Global APS Score (GAPSS)

Area of Science:

• Rheumatology
• Immunology
• Cardiovascular Medicine

Background:

• Antiphospholipid syndrome (APS) is an autoimmune disorder associated with an increased risk of thrombosis and pregnancy complications.
• Accurate risk stratification is crucial for managing APS patients and preventing adverse outcomes.

Purpose of the Study:

• To develop and validate a novel risk score, the Global Antiphospholipid Syndrome Score (GAPSS), for quantitative risk assessment in APS.
• To integrate various risk factors including antiphospholipid antibody profiles, cardiovascular risk factors, and autoimmune markers.

Main Methods:

• Development of the GAPSS by combining independent risk factors for thrombosis and pregnancy loss.
• Inclusion of criteria and non-criteria antiphospholipid antibodies (aPL).
• Incorporation of conventional cardiovascular risk factors and autoimmune antibody profiles.

Main Results:

• The GAPSS successfully integrates multiple risk factors into a single quantitative score.
• Demonstrated that the risk profile in APS can be effectively assessed using the developed score.
• Indicated the potential of GAPSS as a quantitative marker for APS-related clinical manifestations.

Conclusions:

• The Global Antiphospholipid Syndrome Score (GAPSS) provides a comprehensive tool for assessing patient risk.
• GAPSS may aid in personalized management strategies and prediction of clinical outcomes in antiphospholipid syndrome.